Wilmington, DE -- (SBWIRE) -- 08/20/2013 -- Equity Profile Report expands its NYSE Gainers Weekly Watch List adding Health Management Associates Inc. (NYSE:HMA) and Allergan Inc. (NYSE:AGN).
Health Management Associates Inc. (NYSE:HMA) a company that through its subsidiaries, engages in the operation of general acute care hospitals and other health care facilities in non-urban communities in the United States is currently up (+0.35%) on 2,793,424 shares traded after Health Management Associates Inc. confirmed Friday that its shareholders have voted in favor of a new board of directors. Health Management Associates Inc. (NYSE:HMA) is currently up (+88.24%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.
Click Here to find out what other Investors are saying about Health Management Associates Inc. (NYSE:HMA)
Allergan Inc. (NYSE:AGN) operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific is currently up (+3.66%) on 1,950,504 shares traded after Allergan Inc. responded to a proposal by the FDA to allow a generic version of the company's Restasis drug to be launched without clinical trials on humans. Allergan Inc. (NYSE:AGN) is currently up (+14.66%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Gainers Watch List.
Click Here to find out what other Investors are saying about Allergan Inc. (NYSE:AGN)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)